Human microbiome is a collective genome of microorganisms that resides inside and outside of the human body which may be pathogenic or beneficial to the human health. The human microbiome has increasingly becoming an integral part of human health due to the growing number of global initiatives pointing its symbiotic role in the management of human health. As the probiotic-based products have already reached the market, global efforts are now underway to underline the function of the human microbiome as a second genome. Large-scale sequencing experiments have provided insight deeper into understanding the diversity of human microbiome throughout demographics, aiming to reconstruct the global genome sequencing initiatives.
MARKET DYNAMICS
Major factor driving the growth of the global Human Microbiome Sequencing market is the increasing understanding of human microbiome in maintaining human health and its role in modulating other metabolic factors in human body and growing trend towards precision medicines. Growing interests across the healthcare continuum across the world has resulted into increasing research and development activities in an ever-evolving human microbiome sequencing landscape and technological advancements in next-generation sequencing (NGS). Furthermore, growing adoption of human microbiome sequencing among the global population will continue to propel the overall market growth. However, High costs of Human Microbiome Sequencing, Lack of intensive analysis of human microbiome and government regulations, and ethical & legal issues associated with human microbiome sequencing are some of the factors restraining the market growth.
MARKET SCOPE
The Human Microbiome Sequencing market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Human Microbiome Sequencing market with detailed market segmentation by capacity of devices, applications and end users. The Human Microbiome Sequencing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Human Microbiome Sequencing market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Human Microbiome Sequencing market is segmented on the basis of Product Type, Technology, Application and end users. Based on Product type, the market is segmented as Assays kits, Instruments, Software. On the basis of technology market is segmented as Next-Generation Sequencing, Traditional Sequencing Technologies, and other Sequencing Technologies. On the basis of application, the market is segmented as Disease Diagnosis, Drug Discovery, Consumer Wellness, Omics Analysis, and Other Applications. On the basis of end users, market can be segmented as Research and Academic Institutions, Pharmaceutical and Biotechnology Companies, other End Users.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Human Microbiome Sequencing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Human Microbiome Sequencing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Human Microbiome Sequencing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Human Microbiome Sequencing market in these regions.
MARKET PLAYERS
The report covers key developments in the Human Microbiome Sequencing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Human Microbiome Sequencing market are anticipated to have lucrative growth opportunities in the future with the rising demand for Human Microbiome Sequencing in the global market. Below mentioned is the list of few companies engaged in the Human Microbiome Sequencing market.
The report also includes the profiles of key players in Human Microbiome Sequencing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Oxford Nanopore Technologies, Inc.
- Pacific Biosciences of California, Inc.
- Beijing Genomics Institute (BGI) Genomics Co., Ltd
- Charles River Laboratories International Inc.
- Clinical Microbiomics A/S
- Eurofins Scientific SE
- Microbiome Insights Inc.
- Illumina, Inc.
- Novogene Corporation
- QIAGEN N.V.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.